Skip to main content
. 2019 Jul 7;85(9):2076–2088. doi: 10.1111/bcp.13999

Table 2.

Listing of available clinical pharmacogenetic tests

COUNTRY Responses (n) Institutions (n) Insurance coverage Pharmacogenetic tests listed in the survey Additional tests
CYP2C19 CYP2C9 CYP2D6 CYP3A4
CYP3A5
DPYD HLA‐A*31:01 B*15:02 SLCO1B1 TPMT UGT1A1
Low HDI
Eritrea 1 1 N/A x x x x x x x x x
Nigeria 1 1 N/A x x x x x x x x x
Sudan 1 1 ? ? ? ? ? ? ? ?
Medium HDI
Bangladesh 2 2 N/A x x x x x x x x x
India 13 13 It depends
Indonesia 3 3 N/A x x x x x x x x x
Pakistan 1 1 N/A x x x x x x x x x
High HDI
Brazil 6 5 It depends
Iran 2 2 ? ? ? ? ? ? ? ? ?
Jordan 5 3 ? x x x x x x x x
Lebanon 2 2 ? x x x x x
Mexico 2 2 ? x ? ? ? ?
Republic of Moldova 1 1 N/A x x x x x x x x x
Turkey 1 1 ?
Very high HDI—other
Argentina 1 1 x x x x x x CYP2A6, CYP2B6, NAT2, ABCB1, OCT
Australia 2 2 x
Brunei 1 1 N/A x x x x x x x x x
Malaysia 2 2 x x
Saudi Arabia 1 1 ? x x x x x ? x ? ?
Singapore 1 1 x ? ? ? ? HLA‐B*5701, HLA‐B*5801
United Arab Emirates 1 1 ? ? x x ? ? ? x ?
Very high HDI—Europe
Belarus 1 1 x ? ? ABC
Croatia 1 1 x ABCB1, ABCG2, NAT2
Denmark 1 1 x x x ? ? ?
Estonia 1 1 ? ? ? ? ?
France 1 1 ?
Germany 3 3 x ABCB1, ABCG2
Iceland 1 1 N/A x x x x x x x x x
Italy 5 4 x ? ?
Slovenia 3 1 x SLC19A1, SLC6A4, MTHFD1, ABCC2
Spain 4 4 It depends CYP2B6, VKORC1, HLA‐B*5701
Sweden 1 1 x VKORC1, NAT2, IL28B
Switzerland 2 2 It depends
The Netherlands 8 5 HLA‐B*5701
UK 1 1 ? ? ? ? ? ? ? ? ? VKORC1
Very high HDI—North America
Canada 6 6 It depends VKORC1, IL28B, OPRM1, UGT2B15
USA 59 41 It depends CYP2B6, CYP4F2, VKORC1, HLA‐B*5701, HLA‐B*5801, G6PD, OPRD1, OPRM1, GRIK1, GRIK4, INFL3, ITPA, NUDT15, RYR1, mt‐RNR1, CACNAIS, CFTR, ADR2A

HDI: Human Development Index (2018). Number of responses does not total 204 due to missing answers. X = no; √ = yes; ? = uncertain.